CD45.2 Antibody, anti-mouse | Hybridomas | MACS Antibodies | Products | Miltenyi Biotec | Deutschland
Mouse Transplant Models for Evaluating the Oncogenic Risk of a Self-Inactivating XSCID Lentiviral Vector | PLOS ONE
A subpopulation of CD45 2 mTert-GFP + cells immunostain for the... | Download Scientific Diagram
A sex-specific reconstitution bias in the competitive CD45.1/CD45.2 congenic bone marrow transplant model | Scientific Reports
CD45.2 Monoclonal Antibody (104) (14-0454-82)
A sex-specific reconstitution bias in the competitive CD45.1/CD45.2 congenic bone marrow transplant model | Scientific Reports
Figures and data in The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor | eLife
CD45RB Status of CD8+ T Cell Memory Defines T Cell Receptor Affinity and Persistence - ScienceDirect
CD45.2 (104) Mouse mAb (violetFluor™ 500 Conjugate) | Cell Signaling Technology
Competitive Bone Marrow Transplantation in C57/BL6 Mice
Easy To Use Mouse CD45.2 Cell Marker | Biocompare Antibody Review
IJMS | Free Full-Text | Distinction of Microglia and Macrophages in Glioblastoma: Close Relatives, Different Tasks?
Intra-hematopoietic cell fusion as a source of somatic variation in the hematopoietic system
CD45.2 Monoclonal Antibody (104) (14-0454-82)
anti-CD45.2 Antikörper | Produkt Nr. ABIN135324
CD45 characterization & Isoforms - Mini-review | Bio-Rad
A sex-specific reconstitution bias in the competitive CD45.1/CD45.2 congenic bone marrow transplant model | Scientific Reports
A sex-specific reconstitution bias in the competitive CD45.1/CD45.2 congenic bone marrow transplant model | Scientific Reports
1 Supplemental Figures Supplemental Figure 1. Supplemental data for Figure 1. A mixture of 5x10 6 total BM cells (A) or two tho
Parabiosis and single-cell RNA sequencing reveal a limited contribution of monocytes to myofibroblasts in kidney fibrosis
Intra-hematopoietic cell fusion as a source of somatic variation in the hematopoietic system
Cells | Free Full-Text | Competitive sgRNA Screen Identifies p38 MAPK as a Druggable Target to Improve HSPC Engraftment
